Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Heranba Industries Limited (HERANBA.NS)
Mumbai, IN
Heranba Industries Limited, headquartered in Mumbai, India, specializes in the manufacturing, marketing, and sale of a comprehensive range of agrochemicals. The company's extensive product portfolio includes essential intermediate chemicals (e.g., cypermethric acid chloride, high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR) and a wide array of technical-grade active ingredients (such as cypermethrin, deltamethrin, alpha cypermethrin, acephate, lambda cyhalothrin, bifenthrin, tranfluthrin, tricyclazole, hexaconazole, tebuconazole, glyphosate, metribuzin, clodinafop, and bispyribac sodium). Additionally, Heranba provides diverse pesticide formulations, including emulsifiable concentrate, water dispersible granule, suspension concentrate, capsule suspension, oil dispersion, concentrated aqueous emulsions, suspoemulsion, and ZC formulation. These products collectively address various pest control needs, covering insecticides, herbicides, fungicides, and public health applications. Beyond its strong domestic presence within India, the company also boasts an international footprint, exporting its products to approximately 65 countries worldwide. Established in 1992, the company was initially known as Heranba Industrial Chemicals Limited before adopting its current name, Heranba Industries Limited, in July 1996.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.90% | -6.81% | -18.86% | -14.71% | -30.49% | -28.10% | -40.39% | -45.23% | -75.62% | -78.12% | -78.12% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+12.5% ★ Q1'26: -5.4% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%-2,580.5% Q1'26: -39.3% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%-14.5% Q1'26: -46.7% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%-1.8% Q1'26: -15.3% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%-2.2% Q1'26: -12.7% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+0.4% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×8.32× Q1'26: -6.19× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
|---|---|---|---|---|
| Revenue |
14.35B
est: 14.50B (-1.1%)
|
13.11B
est: 13.35B (-1.8%)
|
12.49B
est: 15.71B (-20.5%)
|
14.17B
est: 17.98B (-21.2%)
|
| EBITDA |
2.79B
est: 1.91B (+46.3%)
|
1.68B
est: 1.76B (-4.6%)
|
886.70M
est: 2.07B (-57.1%)
|
1.06B
est: 1.84B (-42.6%)
|
| EBIT |
2.59B
est: 1.61B (+61.5%)
|
1.46B
est: 1.48B (-1.5%)
|
625.60M
est: 1.74B (-64.0%)
|
488.90M
est: 1.29B (-62.0%)
|
| Net Income |
1.89B
est: 2.08B (-9.2%)
|
1.04B
est: 1.32B (-20.7%)
|
348.90M
est: 1.84B (-81.0%)
|
30.70M
est: 2.15B (-98.6%)
|
| SGA |
395.66M
est: 639.25M (-38.1%)
|
670.60M
est: 588.43M (+14.0%)
|
503.10M
est: 692.53M (-27.4%)
|
1.05B
est: 1.39B (-24.4%)
|
| EPS |
47.25
est: 52.20 (-9.5%)
|
26.08
est: 33.00 (-21.0%)
|
8.72
est: 46.10 (-81.1%)
|
0.77
est: 53.70 (-98.6%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hemant | Vice President of HR | — | male |
| Murad Shemle | General Manager of Credit & Legal | — | male |
| Pravin Babu Shetty | Chief Financial Officer (Accounts & Finance) | — | male |
| Raghuram Kanyan Shetty | MD & Director | — | male |
| Raunak Raghuram Shetty | Whole-Time Director | — | male |
| S. D. Namjoshi | Head of Production Units & President of Operations | — | male |
| Sadashiv Kanyana Shetty | Executive Chairman | — | male |
| Satish Tiwari | Vice President Sales & Marketing | — | male |
| Shriraj S. Shetty | Whole-Time Director | — | male |
| Sunil Kumar-Ramashrya Singh | Vice President and Head of Research & Development | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HERANBA.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
